Fluxomic assay-assisted diagnosis orientation ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of cpt2 deficiency
Author(s) :
Fontaine, Monique [Auteur]
Kim, Isabelle [Auteur]
Dessein, Anne-Frédérique [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer (JPArc) - U1172
Mulliez, Karine [Auteur]
Dobbelaere, Dries [Auteur]
Douillard, Claire [Auteur]
Sole, Guilhem [Auteur]
Schiff, Manuel [Auteur]
Jaussaud, Roland [Auteur]
Espil-Taris, Caroline [Auteur]
Boutron, Audrey [Auteur]
Wuyts, Wim [Auteur]
Acquaviva, Cecile [Auteur]
Vianey-Saban, Christine [Auteur]
Roland, Dominique [Auteur]
Joncquel-Chevalier Curt, Marie [Auteur]
Vamecq, Joseph [Auteur]
Kim, Isabelle [Auteur]
Dessein, Anne-Frédérique [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer (JPArc) - U1172
Mulliez, Karine [Auteur]
Dobbelaere, Dries [Auteur]
Douillard, Claire [Auteur]
Sole, Guilhem [Auteur]
Schiff, Manuel [Auteur]
Jaussaud, Roland [Auteur]
Espil-Taris, Caroline [Auteur]
Boutron, Audrey [Auteur]
Wuyts, Wim [Auteur]
Acquaviva, Cecile [Auteur]
Vianey-Saban, Christine [Auteur]
Roland, Dominique [Auteur]
Joncquel-Chevalier Curt, Marie [Auteur]
Vamecq, Joseph [Auteur]
Journal title :
Molecular genetics and metabolism
Abbreviated title :
Mol. Genet. Metab.
Publication date :
2018-02-12
ISSN :
1096-7206
Keyword(s) :
Late presentation
beta-oxidation disorders
Fluxomic study
Mitochondrial fatty acid oxidation
Diagnosis orientation
intermembrane space pool of carnitine
Known and new CPT2 variants
Carnitine palmitoyltransferase type 2
CPT2
Rhabdomyolysis
Deuterated acylcarnitines
Deuterated palmitate
Acylcarnitines
CPT2 deficiency
CPT1
beta-oxidation disorders
Fluxomic study
Mitochondrial fatty acid oxidation
Diagnosis orientation
intermembrane space pool of carnitine
Known and new CPT2 variants
Carnitine palmitoyltransferase type 2
CPT2
Rhabdomyolysis
Deuterated acylcarnitines
Deuterated palmitate
Acylcarnitines
CPT2 deficiency
CPT1
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Carnitine palmitoyltransferase type 2 (CPT2) deficiency, a mitochondrial fatty acid oxidation disorder (MFAOD), is a cause of myopathy in its late clinical presentation. As for other MFAODs, its diagnosis may be evocated ...
Show more >Carnitine palmitoyltransferase type 2 (CPT2) deficiency, a mitochondrial fatty acid oxidation disorder (MFAOD), is a cause of myopathy in its late clinical presentation. As for other MFAODs, its diagnosis may be evocated when blood acylcarnitine profile is abnormal. However, a lack of abnormalities or specificity in this profile is not exclusive of CPT2 deficiency. Our retrospective study reports clinical and biological data in a cohort of 11 patients with circulating acylcarnitine profile unconclusive enough for a specific diagnosis orientation. In these patients, CPT2 gene studies was prompted by prior fluxomic explorations of mitochondrial β-oxidation on intact whole blood cells incubated with pentadeuterated ([16-2322Show less >
Show more >Carnitine palmitoyltransferase type 2 (CPT2) deficiency, a mitochondrial fatty acid oxidation disorder (MFAOD), is a cause of myopathy in its late clinical presentation. As for other MFAODs, its diagnosis may be evocated when blood acylcarnitine profile is abnormal. However, a lack of abnormalities or specificity in this profile is not exclusive of CPT2 deficiency. Our retrospective study reports clinical and biological data in a cohort of 11 patients with circulating acylcarnitine profile unconclusive enough for a specific diagnosis orientation. In these patients, CPT2 gene studies was prompted by prior fluxomic explorations of mitochondrial β-oxidation on intact whole blood cells incubated with pentadeuterated ([16-2322Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Collections :
Submission date :
2021-09-02T07:01:44Z